CME
MET Inhibition in Metastatic NSCLC “In the Spotlight”
Host: Paul Paik, MD Guest: D. Ross Camidge, MD, PhD Guest: Keith Kerr, BSc, MB ChB Drs. Paul Paik, Keith Kerr, and Ross Camidge take us through testing considerations for MET exon 14 skipping mutations and optimal treatment approaches on